NC center wins $8M to study radiation therapy side effects
A research team in the department of oral medicine at Carolinas Medical Center in Charlotte, NC, has been awarded an $8 million National Institutes of
A research team in the department of oral medicine at Carolinas Medical Center in Charlotte, NC, has been awarded an $8 million National Institutes of
A media campaign in Detroit that utilized print, radio, billboards, and mailed surveys was effective in raising public awareness of oral cancer and influencing healthcare
The rates of people dying from cancer are predicted to decline by 17% in the U.K. by 2030, according to new statistics released by Cancer
BioAlliance Pharma has signed a licensing agreement with Vestiq Pharmaceuticals to commercialize its Oravig product in the U.S. for the treatment of oropharyngeal candidiasis in
The amount spent on cigarette advertising and promotion by the largest cigarette companies in the U.S. declined from $9.94 billion in 2008 to $8.53 billion
During the month of October, Patterson Dental and 11 infection-control product companies are teaming to raise funds for the Organization for Safety, Asepsis and Prevention
Several studies have shown that obese patients are at an increased risk for periodontal disease. Now a new study has found that tracking adiposity changes
DentalEZ Group has signed a letter of intent to make Henry Schein the exclusive global distributor of the Identafi oral cancer screening device, a product
Secondhand smoke is accountable for 42,000 deaths annually to nonsmokers in the U.S., including nearly 900 infants, according to a new University of California, San
Thyroid cancer among people with lower socioeconomic status is diagnosed at a more advanced stage, according to new data presented this week at the American
If dental hygienists do not integrate the growing evidence on the oral-systemic link into their practices, they will have forfeited a great opportunity to define
Human papillomavirus (HPV) DNA positivity alone, particularly when assessed using polymerase chain reaction methods, is a poor biomarker for HPV-driven head and neck cancers (HNCs),